Patents by Inventor Anthony Keller

Anthony Keller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10364535
    Abstract: A method of forming a pavement construction joint that involves dispensing a band of a void reducing joint composition on a substrate using at least one spray application vehicle, wherein the band comprises a width of about 4 to about 24 inches. A paving pass is applied over the band of joint composition, wherein the paving pass is positioned against an edge of a previously laid portion of pavement to form a pavement construction joint having a volume of air voids. At least a portion of the joint composition migrates upward to reduce the volume of air voids. The composition is resistant to flow when applied and migrates into hot mix asphalt in the area of the longitudinal joint to reduce air voids to 7% or less and reduce water permeability. The composition becomes tack-free quickly after application. The composition bonds to asphalt, concrete, brick, stone and metal.
    Type: Grant
    Filed: February 14, 2019
    Date of Patent: July 30, 2019
    Assignee: Heritage Research Group
    Inventors: Anthony J. Kriech, Herbert L. Wissel, Timothy P. Reece, Marvin Keller Exline
  • Publication number: 20190177925
    Abstract: A method of forming a pavement construction joint that involves dispensing a band of a void reducing joint composition on a substrate using at least one spray application vehicle, wherein the band comprises a width of about 4 to about 24 inches. A paving pass is applied over the band of joint composition, wherein the paving pass is positioned against an edge of a previously laid portion of pavement to form a pavement construction joint having a volume of air voids. At least a portion of the joint composition migrates upward to reduce the volume of air voids. The composition is resistant to flow when applied and migrates into hot mix asphalt in the area of the longitudinal joint to reduce air voids to 7% or less and reduce water permeability. The composition becomes tack-free quickly after application. The composition bonds to asphalt, concrete, brick, stone and metal.
    Type: Application
    Filed: February 14, 2019
    Publication date: June 13, 2019
    Inventors: Anthony J. Kriech, Herbert L. Wissel, Timothy P. Reece, Marvin Keller Exline
  • Publication number: 20180214373
    Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.
    Type: Application
    Filed: December 1, 2017
    Publication date: August 2, 2018
    Applicant: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
  • Publication number: 20180092838
    Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.
    Type: Application
    Filed: November 22, 2017
    Publication date: April 5, 2018
    Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
  • Patent number: 9855212
    Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: January 2, 2018
    Assignee: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
  • Patent number: 9839609
    Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: December 12, 2017
    Assignee: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
  • Patent number: 8524657
    Abstract: The present invention provides a compound of formula I, II, III and IV as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.
    Type: Grant
    Filed: August 2, 2011
    Date of Patent: September 3, 2013
    Assignee: University of Wollongong
    Inventors: Timothy Patrick Boyle, John Barnard Bremmer, Zinka Brkic, Jonathan Alan Victor Coates, Neal Kevin Dalton, John Joseph Deadman, Paul Anthony Keller, Jody Morgan, Stephen Geoffrey Pyne, David Ian Rhodes, Mark James Robertson
  • Publication number: 20130045941
    Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.
    Type: Application
    Filed: October 29, 2010
    Publication date: February 21, 2013
    Applicant: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
  • Publication number: 20120207827
    Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.
    Type: Application
    Filed: October 29, 2010
    Publication date: August 16, 2012
    Applicant: Abela Pharmaceuticals, Inc.
    Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
  • Patent number: 8217085
    Abstract: Embodiments of the invention relate generally to the use of compositions comprising methylsulfonylmethane (MSM), and one or more therapeutic agents, for the treatment of drug-sensitive and drug resistant microorganisms. In several embodiments, such compositions are effective in treating drug resistant infectious diseases, for example, MRSA.
    Type: Grant
    Filed: February 17, 2012
    Date of Patent: July 10, 2012
    Assignee: Biogenic Innovations, LLC
    Inventors: Rodney Benjamin, Jeffrey Varelman, Anthony Keller
  • Publication number: 20120149672
    Abstract: Embodiments of the invention relate generally to the use of compositions comprising methylsulfonylmethane (MSM), and one or more therapeutic agents, for the treatment of drug-sensitive and drug resistant microorganisms. In several embodiments, such compositions are effective in treating drug resistant infectious diseases, for example, MRSA.
    Type: Application
    Filed: February 17, 2012
    Publication date: June 14, 2012
    Inventors: Rodney Benjamin, Jeffrey Varelman, Anthony Keller
  • Publication number: 20110312875
    Abstract: The present invention provides a compound of formula I, II, III and IV as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.
    Type: Application
    Filed: August 2, 2011
    Publication date: December 22, 2011
    Applicant: UNIVERSITY OF WOLLONGONG
    Inventors: Timothy Patrick Boyle, John Barnard Bremner, Zinka Brkic, Jonathan Alan Victor Coates, Neal Kevin Dalton, John Deadman, Paul Anthony Keller, Jody Morgan, Stephen Geoffrey Pyne, David Ian Rhodes, Mark James Robertson
  • Patent number: 8039430
    Abstract: The present invention provides a compound of formula (I), (II), (III) and (IV) as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.
    Type: Grant
    Filed: September 21, 2005
    Date of Patent: October 18, 2011
    Assignee: University of Wollongong
    Inventors: Timothy Patrick Boyle, John Barnard Bremner, Zinka Brkic, Jonathan Alan Victor Coates, Neal Kevin Dalton, John Joseph Deadman, Paul Anthony Keller, Jody Morgan, Stephen Geoffrey Pyne, David Ian Rhodes, Mark James Robertson
  • Publication number: 20080300287
    Abstract: The present invention provides a compound of formula (I), (II), (III) and (IV) as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.
    Type: Application
    Filed: September 21, 2005
    Publication date: December 4, 2008
    Applicant: UNIVERSITY OF WOLLONGONG
    Inventors: Timothy Patrick Boyle, John Barnard Bremner, Zinka Brkic, Jonathan Alan Victor Coates, Neal Kevin Dalton, John Deadman, Paul Anthony Keller, Jody Morgan, Stephen Geoffrey Pyne, David Ian Rhodes, Mark James Robertson